Neuland Laboratories Ltd Share Price Neuland Labs.

463.00

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)

465.25

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)
Detailed Quote

Corporate Action

Period From
Period To
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 16-Jan-2020 - -
NEULAND LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2020 ,inter alia, to consider and approve the Unaudited Financial Results for the Quarter ended December 31, 2019 We refer to our letter dated January 16, 2020, intimating that a meeting of the Board of Directors of the Company would be held on Tuesday, February 11, 2020, inter alia, to consider the Unaudited Financial Results of the Company for the quarter ended December 31, 2019. Further to the afore-mentioned letter, we would like to inform that the Board of Directors, at the Board Meeting scheduled on February 11, 2020, would, inter alia, also consider the declaration of interim dividend for the financial year 2019-20, if any, along with the Unaudited Financial Results for the quarter ended December 31, 2019. Pursuant to Regulation 42 of the SEBI (LODR) Regulations, 2015, we also inform you that subject to the afore-mentioned declaration by the Board of Directors, Friday, February 14, 2020, shall be the Record Date for the purpose of payment of interim dividend. We refer to our letter dated February 4, 2020, intimating that the meeting of the Board of Directors of the Company scheduled to be held on Tuesday, February 11, 2020, inter alia, shall consider declaration of interim dividend for the financial year 2019-20, if any, along with the Unaudited Financial Results for the quarter ended December 31, 2019 and 14th February, 2020 as the Record Date for payment of interim dividend, if any. Further to our afore-mentioned letter, we would like to inform you that the Record Date for the purpose of payment of interim dividend, if declared by the Board of Directors, shall be Thursday, February 20, 2020. (As Per BSE Announcement Dated on 04.02.2020) Pursuant to Regulation 30 and 33 of SEBI Listing Regulations, 2015, we wish to inform you that the Board of Directors at their meeting held on even date, i.e. February 11, 2020, has inter alia: i. approved the Un-audited Standalone & Consolidated Financial Results for the quarter and nine months ended December 31, 2019, which have been reviewed by the Audit Committee. ii. declared and approved payment of Interim Dividend @ Rs.2.00/- (20%) per equity share of Rs. 10/- each for the Financial Year 2019-20. iii. approved the re-appointment of Dr. Nirmala Murthy as Independent Director for a term of five years with effect from May 8, 2020, subject to the approval of the Members of the Company. Further, as earlier intimated, the Record date for the said Interim Dividend is Thursday, February 20, 2020. Please find attached herewith copies of the newspaper publication of Un-audited Financial Results for the quarter and nine months ended December 31, 2019, published in Financial Express and Andhra Prabha on February 12, 2020 for your reference. (As Per BSE Announcement Dated on 11.02.2020)
Board Meeting - 30-Oct-2019 - -
NEULAND LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2019 ,inter alia, to consider and approve the unaudited financial results for the quarter and half-year ended September 30, 2019. Results Release and Earnings Call Notice under Regulation 30 SEBI (Listing Obligations and Disclosure Requirements), 2015 (As Per BSE Announcement Dated on 07.11.2019) This is to inform you that the Board of Directors, at their meeting held on even date, has inter alia, approved the Unaudited Financial Results (standalone & consolidated) of the Company for the quarter and half-year ended September 30, 2019. Please find enclosed the financial results for the quarter and half-year ended September 30, 2019, along with a copy of the limited review reports (standalone & consolidated) by the Statutory auditors of the Company. The meeting of the Board of Directors of the Company commenced at 01:15 pm and concluded at 03:30 pm (As Per BSE Announcement Dated on 14/11/2019) Please find attached herewith copies of the newspaper publication of Un-audited financial results for the quarter and half year ended September 30, 2019, published in Financial Express and Andhra Prabha on November 15, 2019 for your reference. (As per BSE Announcement Dated on 15.11.2019)
Board Meeting - 16-Jul-2019 - -
NEULAND LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2019 ,inter alia, to consider and approve To consider and approve the in-audited financial results for the quarter ended June 30, 2019 Newspaper publication dated July 17, 2019 (As Per BSE Announcement Dated 17.07.2019) Outcome of Board Meeting (As Per BSE Announcement Dated On 13/08/2019)
Board Meeting - 03-Apr-2019 - -
NEULAND LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2019 ,inter alia, to consider and approve To consider and take on record the Audited financial results of the Company for the year ended March 31, 2019 Publication of Notice of Board Meeting (As Per BSE Announcement Dated On 04/04/2019) Company Update (As Per BSE Announcement Dated On 02/05/2019) Board approved Dividend for FY 2018-19 Audited Financial Results for quarter and Financial year ended March 31, 2019 Outcome of Board Meeting held on May 16, 2019 Disclosure under Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements), Regulations, 2015 (As Per BSE Announcement Dated on 16.05.2019)
Open Demat Account